The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Meta‐analysis of early nonmotor features and risk factors for Parkinson disease
Open accessAbstract
Objective: To evaluate the association between diagnosis of Parkinson disease (PD) and risk factors or early symptoms amenable to population‐based screening. Methods: A systematic review and meta‐analysis of risk factors for PD. Results: The strongest associations with later diagnosis of PD were found for having a first‐degree or any relative with PD (odds ratio [OR], 3.23; 95% confidence interval [CI], 2.65–3.93 and OR, 4.45; 95% CI, 3.39–5.83) or any relative with tremor (OR, 2.74; 95% CI, 2.10–3.57), constipation (relative risk [RR], 2.34; 95% CI, 1.55–3.53), or lack of smoking history (current vs never: RR, 0.44; 95% CI, 0.39–0.50), each at least doubling the risk of PD. Further positive significant associations were found for history of anxiety or depression, pesticide exposure, head injury, rural living, beta‐blockers, farming occupation, and well‐water drinking, and negative significant associations were found for coffee drinking, hypertension, nonsteroidal anti‐inflammatory drugs, calcium channel blockers, and alcohol, but not for diabetes mellitus, cancer, oral contraceptive pill use, surgical menopause, hormone replacement therapy, statins, acetaminophen/paracetamol, aspirin, tea drinking, history of general anesthesia, or gastric ulcers. In the systematic review, additional associations included negative associations with raised serum urate, and single studies or studies with conflicting results. Interpretation: The strongest risk factors associated with later PD diagnosis are having a family history of PD or tremor, a history of constipation, and lack of smoking history. Further factors also but less strongly contribute to risk of PD diagnosis or, as some premotor symptoms, require further standardized studies to demonstrate the magnitude of risk associated with them. ANN NEUROL 2012
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
(2014) · Medical Entomology and Zoology · Cited by 17,633
Duval, S., & Tweedie, R. (2000) · Biometrics · doi:10.1111/j.0006-341x.2000.00455.x · Cited by 14,099
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · cited 1×
“Both constipation and mood disorders have been suggested to correlate with brainstem involvement that, together with olfactory bulb involvement, occurs early in PD and later spreads to the substantia nigra and to the cortex.(41) This theory would also support a role for hyposmia, erectile dysfunction, and excessive da…”
BackgroundDiagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069
Self-citationChronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914
Meta-analysis: Principles and procedures
Egger, M., Smith, G. D., & Phillips, A. N. (1997) · BMJ · doi:10.1136/bmj.315.7121.1533 · Cited by 2,415
Neuroinflammation in Parkinson’s disease: A target for neuroprotection?
Hirsch, E. C., & Hunot, S. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70062-6 · Cited by 1,984
ETIOLOGY AND PATHOGENESIS OF PARKINSON'S DISEASE
Olanow, C. W., & Tatton, W. G. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.123 · Cited by 1,396
Schenck, C. H., Bundlie, S. R., & Mahowald, M. W. (1996) · Neurology · doi:10.1212/wnl.46.2.388 · Cited by 1,083
A meta‐analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease
Hernán, M. A., Takkouche, B., Caamaño‐Isorna, F., & Gestal‐Otero, J. J. (2002) · Annals of Neurology · doi:10.1002/ana.10277 · Cited by 818
Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder
Postuma, R. B., Gagnon, J. F., Vendette, M., Fantini, M. L., Massicotte-Marquez, J., & Montplaisir, J. (2009) · Neurology · doi:10.1212/01.wnl.0000340980.19702.6e · Cited by 767
Association of olfactory dysfunction with risk for future Parkinson's disease
Ross, G. W., Petrovitch, H., Abbott, R. D., Tanner, C. M., Popper, J., Masaki, K., Launer, L., & White, L. R. (2008) · Annals of Neurology · doi:10.1002/ana.21291 · Cited by 742
Are men at greater risk for Parkinson's disease than women?
Wooten, G. F. (2004) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.020982 · Cited by 695
Environmental Risk Factors and Parkinson's Disease: A Metaanalysis
Priyadarshi, A., Khuder, S. A., Schaub, E. A., & Priyadarshi, S. S. (2001) · Environmental Research · doi:10.1006/enrs.2001.4264 · Cited by 446
Excessive daytime sleepiness and subsequent development of Parkinson disease
Abbott, R. D., Ross, G. W., White, L. R., Tanner, C. M., Masaki, K. H., Nelson, J. S., Curb, J. D., & Petrovitch, H. (2005) · Neurology · doi:10.1212/01.wnl.0000183056.89590.0d · Cited by 440
Pesticides and Parkinson’s Disease—Is There a Link?
Brown, T. P., Rumsby, P. C., Capleton, A. C., Rushton, L., & Levy, L. S. (2006) · Environmental Health Perspectives · doi:10.1289/ehp.8095 · Cited by 430
Altered Uric Acid Levels and Disease States
Kutzing, M. K., & Firestein, B. L. (2008) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.129031 · Cited by 374
Pooled Analysis of Tobacco Use and Risk of Parkinson Disease
Ritz, B., Ascherio, A., Checkoway, H., Marder, K. S., Nelson, L. M., Rocca, W. A., Ross, G. W., Strickland, D., Van Den Eeden, S. K., & Gorell, J. (2007) · Archives of Neurology · doi:10.1001/archneur.64.7.990 · Cited by 370
Incidence of parkinsonism and Parkinson disease in a general population: The Rotterdam Study
de Lau, L. M. L., Giesbergen, P. C. L. M., de Rijk, M. C., Hofman, A., Koudstaal, P. J., & Breteler, M. M. B. (2004) · Neurology · doi:10.1212/01.wnl.0000140706.52798.be · Cited by 360
Smoking, nicotine and Parkinson's disease
Quik, M. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.06.008 · Cited by 324
Anti-inflammatory drugs and risk of Parkinson disease: A meta-analysis
Gagne, J. J., & Power, M. C. (2010) · Neurology · doi:10.1212/wnl.0b013e3181d5a4a3 · Cited by 322
A meta-analysis of Parkinson's disease and exposure to pesticides.
Priyadarshi, A., Khuder, S., Schaub, E. A., & Shrivastava, S. (2000) · PubMed · Cited by 319
Peripheral Inflammatory Biomarkers and Risk of Parkinson's Disease
Chen, H., O'Reilly, E. J., Schwarzschild, M. A., & Ascherio, A. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm260 · Cited by 317
A systematic review of depression and mental illness preceding Parkinson's disease
Ishihara, L., & Brayne, C. (2006) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2006.00579.x · Cited by 313
When Does Parkinson Disease Start?
Savica, R., Rocca, W. A., & Ahlskog, J. E. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.135 · Cited by 312
Incidence and remaining lifetime risk of Parkinson disease in advanced age
Driver, J. A., Logroscino, G., Gaziano, J. M., & Kurth, T. (2009) · Neurology · doi:10.1212/01.wnl.0000341769.50075.bb · Cited by 298
Nonmotor symptoms as presenting complaints in Parkinson’s disease: a clinicopathological study
O'Sullivan, S. S., Williams, D. R., Gallagher, D. A., Massey, L. A., Silveira‐Moriyama, L., & Lees, A. J. (2008) · Movement Disorders · doi:10.1002/mds.21813 · Cited by 290
Self-citationIntake of vitamin E, vitamin C, and carotenoids and the risk of Parkinson's disease: a meta-analysis
Etminan, M., Gill, S. S., & Samii, A. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70097-1 · Cited by 279
Diagnosis and the premotor phase of Parkinson disease
Tolosa, E., Gaig, C., Santamaría, J., & Compta, Y. (2009) · Neurology · doi:10.1212/wnl.0b013e318198db11 · Cited by 255
Smoking and Parkinson’s and Alzheimer’s disease: review of the epidemiological studies
Fratiglioni, L., & Wang, H.-X. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00206-0 · Cited by 245
Parkinson’s disease and cancer risk: a systematic review and meta-analysis
Bajaj, A., Driver, J. A., & Schernhammer, E. S. (2010) · Cancer Causes & Control · doi:10.1007/s10552-009-9497-6 · Cited by 244
Is Pesticide Use Related to Parkinson Disease? Some Clues to Heterogeneity in Study Results
van der Mark, M., Brouwer, M., Kromhout, H., Nijssen, P., Huss, A., & Vermeulen, R. (2012) · Environmental Health Perspectives · doi:10.1289/ehp.1103881 · Cited by 238
Prospective Study of Cigarette Smoking and the Risk of Developing Idiopathic Parkinson's Disease
Grandinetti, A., Morens, D. M., Reed, D., & MacEachern, D. (1994) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116960 · Cited by 220
Symptoms and duration of the prodromal phase in parkinson's disease
Gonera, E. G., Hof, M. V., Berger, H. J. C., van Weel, C., & Horstink, M. W. I. M. (1997) · Movement Disorders · doi:10.1002/mds.870120607 · Cited by 213
The prodromal phase of sporadic Parkinson's disease: Does it exist and if so how long is it?
Hawkes, C. H. (2008) · Movement Disorders · doi:10.1002/mds.22242 · Cited by 192
Self-citationSmoking and Parkinson's disease: Systematic review of prospective studies
Allam, M. F., Campbell, M. J., Hofman, A., Del Castillo, A. S., & Fernández‐Crehuet Navajas, R. (2004) · Movement Disorders · doi:10.1002/mds.20029 · Cited by 192
Smoking and Parkinson’s disease in twins
Tanner, C. M., Goldman, S. M., Aston, D. A., Ottman, R., Ellenberg, J., Mayeux, R., & Langston, J. W. (2002) · Neurology · doi:10.1212/wnl.58.4.581 · Cited by 182
Meta-analysis of the relationship between Parkinson disease and melanoma
Liu, R., Gao, X., Lu, Y., & Chen, H. (2011) · Neurology · doi:10.1212/wnl.0b013e31821e554e · Cited by 160
Traumatic Encephalopathy (`Punch Drunk') of Professional Pugilists
Parker, H. L. (1934) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.s1-15.57.20 · Cited by 144
Risk and protective factors for Parkinson's disease: A study in Swedish twins
Wirdefeldt, K., Gatz, M., Yudi Pawitan, Y., & Pedersen, N. L. (2004) · Annals of Neurology · doi:10.1002/ana.20307 · Cited by 144
Rees, K., Stowe, R. L., Patel, S., Ives, N. J., Breen, K. C., Clarke, C. E., & Ben‐Shlomo, Y. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008454.pub2 · Cited by 136
Rees, K., Stowe, R. L., Patel, S., Ives, N. J., Breen, K. C., Clarke, C. E., & Ben‐Shlomo, Y. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008454 · Cited by 130
Erectile Function and Risk of Parkinson's Disease
Gao, X., Chen, H., Schwarzschild, M. A., Glasser, D. B., Logroscino, G., Rimm, E. B., & Ascherio, A. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm246 · Cited by 125
Evaluation of Epidemiologic and Animal Data Associating Pesticides With Parkinson???s Disease
Li, A. A., Mink, P. J., McIntosh, L. J., Teta, M. J., & Finley, B. L. (2005) · Journal of Occupational and Environmental Medicine · doi:10.1097/01.jom.0000174294.58575.3e · Cited by 101
A Case-Control Study on Cigarette, Alcohol, and Coffee Consumption Preceding Parkinson’s Disease
Ragonese, P., Salemi, G., Morgante, F., Aridon, P., Epifanio, A., Buffa, D. J., Scoppa, F., & Savettieri, G. (2003) · Neuroepidemiology · doi:10.1159/000071193 · Cited by 96
Premotor Parkinson's disease: Clinical features, detection, and prospects for treatment
Siderowf, A. D., & Stern, M. B. (2009) · Annals of Neurology · doi:10.1002/ana.21462 · Cited by 96
Subjective Complaints Precede Parkinson Disease: The Rotterdam Study
de Lau, L. M. L., Koudstaal, P. J., Albert Hofman, D., & Breteler, M. M. B. (2006) · Archives of Neurology · doi:10.1001/archneur.63.3.noc50312 · Cited by 87
Use of Statins and the Risk of Parkinson???s Disease: A Retrospective Case-Control Study in the UK
Becker, C., Jick, S. S., & Meier, C. R. (2008) · Drug Safety · doi:10.2165/00002018-200831050-00004 · Cited by 67
Morens, D. M., Grandinetti, A., Davis, J. W., Ross, G. W., White, L. R., & REED, D. M. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008941 · Cited by 60
Cochrane Collaboration: more than systematic reviews?
Green, S., & McDonald, S. J. (2005) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2004.00747.x · Cited by 27
Parkinson’s Disease Protects Against Smoking?
Allam, M. F., Campbell, M. J., del Castillo, A. S., & Navajas, R. F. (2004) · Behavioural Neurology · doi:10.1155/2004/516302 · Cited by 27
Perceived imbalance and risk of Parkinson's disease
Gao, X., Chen, H., Schwarzschild, M. A., Logroscino, G., & Ascherio, A. (2008) · Movement Disorders · doi:10.1002/mds.21919 · Cited by 26
Parkinson's disease, smoking and family history: meta‐analysis
Allam, M. F., del Castillo, A. S., & Navajas, R. F. ‐. (2003) · European Journal of Neurology · doi:10.1046/j.1468-1331.2003.00512.x · Cited by 19
Cited by
Kalia, L. V., & Lang, A. E. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61393-3 · Cited by 6,184
Bloem, B. R., Okun, M. S., & Klein, C. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00218-x · Cited by 3,920
Gut microbiota are related to Parkinson's disease and clinical phenotype
Scheperjans, F., Aho, V., Pereira, P. A. B., Koskinen, K., Paulin, L., Pekkonen, E., Haapaniemi, E., Kaakkola, S., Eerola‐Rautio, J., Pohja, M., et al. (2015) · Movement Disorders · doi:10.1002/mds.26069 · Cited by 1,968
Pharmacological Treatment of Parkinson Disease: A Review
Connolly, B. S., & Lang, A. E. (2014) · JAMA · doi:10.1001/jama.2014.3654 · Cited by 1,498
Inflammation and immune dysfunction in Parkinson disease
Tansey, M. G., Wallings, R. L., Houser, M. C., Herrick, M. K., Keating, C. E., & Joers, V. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-022-00684-6 · Cited by 1,382
Metadata
- Authors
- Noyce, A. J., Bestwick, J. P., Silveira‐Moriyama, L., Hawkes, C. H., Giovannoni, G., Lees, A. J., & Schrag, A.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2012-10-15
- Volume
- 72
- Issue
- 6
- Pages
- 893-901
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W1993790483
- Cited by
- 778
- References
- 59
- FWCI
- 25.43
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.